ApicHope Pharmaceutical Co., Ltd

300723

CNE1000035J7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
22.93 ^CNY	-3.98%		+0.84%	-23.13%

Apr. 26	ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 26	ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

ApicHope Pharmaceutical Co., Ltd's Equity Buyback announced on May 10, 2022 has expired.

May 08, 2022

The company expire its plan on May 9, 2022.

Latest news about ApicHope Pharmaceutical Co., Ltd

ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
ApicHope Pharmaceutical's Unit Obtains Registration Certificate for Pentoxifylline Injection; Shares Up 6%	23-10-13	MT
ApicHope's Unit Gains Drug Regulator's Nod for Carbocysteine Oral Solution Usage Amendments	23-09-07	MT
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Chinese healthcare stocks hit by stepped up anti-graft crackdown	23-08-09	RE
Apichope Pharmaceutical Co., Ltd Announces Final Cash Dividend on Share A for 2022, Payable on May 24, 2023	23-05-17	CI
ApicHope Pharmaceutical Co., Ltd Approves Cash Dividend for the Year 2022	23-05-12	CI
Apichope Pharmaceutical Co., Ltd Proposes Final Dividend for 2022	23-04-20	CI
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
ApicHope Pharma Applies to Have Blood Clot Drug Added to China’s Drug Procurement Scheme	23-03-30	MT
ApicHope Registers Hemorrhage Injection Drug; Shares Fall 7%	23-01-05	MT
ApicHope Pharmaceutical Unit Gets Regulatory Nod For Registration of Anti-Bacterial Drug	22-12-08	MT
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-19	CI
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-28	CI
Apichope Pharmaceutical Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 25 May 2022	22-05-18	CI
Apichope Pharmaceutical Co., Ltd Approves 2021 Profit Distribution Plan At the Annual General Meeting Held on May 12, 2022	22-05-13	CI
ApicHope Pharmaceutical Co., Ltd's Equity Buyback announced on May 10, 2022 has expired.	22-05-08	CI
Apichope Pharmaceutical Co., Ltd Proposes Final Dividend for the Year 2021	22-04-21	CI
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI
ApicHope Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-20	CI
Tranche Update on ApicHope Pharmaceutical Co., Ltd's Equity Buyback Plan announced on May 11, 2021.	22-04-01	CI
Tranche Update on ApicHope Pharmaceutical Co., Ltd's Equity Buyback Plan announced on May 11, 2021.	22-01-04	CI
ApicHope Pharmaceutical Adopts New Name	21-12-09	MT

Chart ApicHope Pharmaceutical Co., Ltd

Duration

Period

More charts

ApicHope Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of drugs. The Company has two types of products which are children's drugs and chronic disease drugs. The children's drugs are used for the treatment of colds, digestive anorexia, viral infections, children's eczema and other diseases, including clindamycin palmitate dispersible tablets and clindamycin palmitate granules. The chronic disease drugs include hepatocyte growth-promoting hormone for injection, aceglutamine for injection and adenosine cyclophosphate for injection, which are used for the treatment of severe viral hepatitis and cardiovascular and cerebrovascular diseases. The Company is also engaged in selling drugs for agents.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for ApicHope Pharmaceutical Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.93 CNY

Average target price

30.31 CNY

Spread / Average Target

+32.18%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
APICHOPE PHARMACEUTICAL CO., LTD	-23.13%	1.42B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.27B
OTSUKA HOLDINGS CO., LTD.	+24.52%	22.92B
SANDOZ GROUP AG	+20.29%	15.43B
CIPLA LIMITED	+7.48%	12.95B
ZYDUS LIFESCIENCES LIMITED	+42.51%	11.83B
ONO PHARMACEUTICAL CO., LTD.	-8.84%	6.91B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.13%	5.55B

Generic Pharmaceuticals